Lee Schacter joins Clinipace
This article was originally published in Scrip
Clinipace, a global digital contract research organization (dCRO), has named Dr Lee Schacter executive medical director, oncology. Dr Schacter will provide strategic guidance, program design, and medical oversight to clients conducting oncology development programs. Prior to joining Morrisville, North Carolina-based Clinipace, Dr Schacter was an independent consultant with Phasen Consulting, during which time he was CMO of the Multiple Myeloma Research Foundation, worked with Janssen R&D, and was medical director for marketed oncology products at AstraZeneca.
You may also be interested in...
Angeli Möller, recently spotlighted by In Vivo as a 2020 Rising Leader, has quickly moved up the ranks at Bayer and is now spearheading one of its key initiatives to bring artificial intelligence and machine learning technologies into the pharma business.
Coaching and mentoring are important tools for the leaders of today to be able to foster the next generation of talent in the biopharma sector. While the routes into industry have not changed dramatically – most leaders hold a master’s degree and/or PhD – the expectations of rising leaders have altered and the industry itself has become more collaborative.
In this first edition of In Vivo's ‘Rising Leaders’ list, the focus is on entrepreneurs and innovators who represent the next wave of creativity in health care.